Impact of Transarterial Chemoembolization or Hepatic Artery Infusion Chemotherapy on Liver Function after Hepatocellular Carcinoma Resection: An Observational Study

被引:3
作者
Yue, Rongbin [1 ]
Liu, Xiqiang [1 ]
机构
[1] Sun Yat Sen Univ, Affiliated Hosp 5, Div Hepatol, Zhuhai, Peoples R China
关键词
Hepatocellular carcinoma; Transarterial chemoembolization; Hepatic artery infusion chemotherapy; Liver function; Postoperation; POSTOPERATIVE TACE; TUMOR THROMBUS; FAILURE; 5-FLUOROURACIL; PROGNOSIS; MRI; HCC;
D O I
10.1159/000528750
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Introduction: Liver surgery leads to a high degree of heterogeneity in the prognosis of hepatocellular carcinoma (HCC) patients. However, most previous studies focused on the postoperative therapeutic effects of other treatments, with relatively few studies on the impacts on liver function. This study investigated the impact of transarterial chemoembolization (TACE) and hepatic artery infusion chemotherapy (HAIC) on liver function after HCC resection from various angles. Methods: 138 HCC patients were enrolled, including 27 patients who received TACE and 80 patients who received HAIC. Besides routine treatment such as liver protection and antiviral therapy, 31 patients received no other treatment. The different groups were compared with various biological parameters with four types of scoring methods. Results: In the short term after TACE, the mean (+/- SD) alanine transaminase and aspartate transaminase values increased by 79.22 +/- 117.43 U/L and 66.33 +/- 94.54 U/L, respectively (p < 0.01). The mean (+/- SD) total bilirubin (TBIL) values increased by 4.02 +/- 6.08 mu mol/L (p < 0.01). The mean (+/- SD) albumin (ALB) values decreased by 3.54 +/- 2.93 g/L (p < 0.001). The mean (+/- SD) albumin bilirubin (ALBI) scores increased by 0.39 +/- 0.22 (p < 0.001). In the short term after HAIC, the mean (+/- SD) TBIL values increased by 2.11 +/- 5.57 mu mol/L (p < 0.01). The mean (+/- SD) ALB values decreased by 2.52 +/- 3.26 g/L (p < 0.001), and the mean (+/- SD) ALBI scores increased by 0.21 +/- 0.42 (p < 0.001). In both treatment groups, the long-term liver function was not significantly different from that before treatment and also from that of the untreated group (p > 0.05). Conclusion: TACE after HCC resection has a significant impact on short-term liver function, whereas HAIC has a relatively small impact, but neither has a major impact on long-term liver function.
引用
收藏
页码:291 / 298
页数:8
相关论文
共 35 条
  • [1] Asahara T, 1999, HEPATO-GASTROENTEROL, V46, P1042
  • [2] Post-hepatectomy liver failure after major hepatic surgery: not only size matters
    Asenbaum, Ulrika
    Kaczirek, Klaus
    Ba-Ssalamah, Ahmed
    Ringl, Helmut
    Schwarz, Christoph
    Waneck, Fredrik
    Fitschek, Fabian
    Loewe, Christian
    Nolz, Richard
    [J]. EUROPEAN RADIOLOGY, 2018, 28 (11) : 4748 - 4756
  • [3] Hepatobiliary Cancers, Version 2.2021
    Benson III, Al B.
    D'Angelica, Michael I.
    Abbott, Daniel E.
    Anaya, Daniel A.
    Anders, Robert
    Are, Chandrakanth
    Bachini, Melinda
    Borad, Mitesh
    Brown, Daniel
    Burgoyne, Adam
    Chahal, Prabhleen
    Chang, Daniel T.
    Cloyd, Jordan
    Covey, Anne M.
    Glazer, Evan S.
    Goyal, Lipika
    Hawkins, William G.
    Iyer, Renuka
    Jacob, Rojymon
    Kelley, R. Kate
    Kim, Robin
    Levine, Matthew
    Palta, Manisha
    Park, James O.
    Raman, Steven
    Reddy, Sanjay
    Sahai, Vaibhav
    Schefter, Tracey
    Singh, Gagandeep
    Stein, Stacey
    Vauthey, Jean-Nicolas
    Venook, Alan P.
    Yopp, Adam
    McMillian, Nicole R.
    Hochstetler, Cindy
    Darlow, Susan D.
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2021, 19 (05): : 541 - 565
  • [4] Modern insights into hepatic arterial infusion for liver metastases from colorectal cancer
    Bouchahda, M.
    Levi, F.
    Adam, R.
    Rougier, R.
    [J]. EUROPEAN JOURNAL OF CANCER, 2011, 47 (18) : 2681 - 2690
  • [5] The value of gadoxetate disodium-enhanced MR imaging for predicting posthepatectomy liver failure after major hepatic resection: A preliminary study
    Cho, Seung Hyun
    Kang, Ung Rae
    Kim, Joo Dong
    Han, Young Seok
    Choi, Dong Lak
    [J]. EUROPEAN JOURNAL OF RADIOLOGY, 2011, 80 (02) : E195 - E200
  • [6] Can contrast-enhanced MRI with gadoxetic acid predict liver failure and other complications after major hepatic resection?
    Costa, A. F.
    St-Germain, A. Tremblay
    Abdolell, M.
    Smoot, R. L.
    Cleary, S.
    Jhaveri, K. S.
    [J]. CLINICAL RADIOLOGY, 2017, 72 (07) : 598 - 605
  • [7] Surgical resection combined with chemotherapy for advanced hepatocellular carcinoma with tumor thrombus: Report of 19 cases
    Fukuda, S
    Okuda, K
    Imamura, M
    Imamura, I
    Eriguchi, N
    Aoyagi, S
    [J]. SURGERY, 2002, 131 (03) : 300 - 310
  • [8] Prospective case-controlled trial of adjuvant chemotherapy after resection of hepatocellular carcinoma
    Huang, YH
    Wu, JC
    Lui, WY
    Chau, GY
    Tsay, SH
    Chiang, JH
    King, KL
    Huo, TI
    Chang, FY
    Lee, SD
    [J]. WORLD JOURNAL OF SURGERY, 2000, 24 (05) : 551 - 555
  • [9] Concurrent partial splenic embolization with transcatheter arterial chemoembolization for hepatocellular carcinoma can maintain hepatic functional reserve
    Ishikawa, Toru
    Kubota, Tomoyuki
    Horigome, Ryoko
    Kimura, Naruhiro
    Honda, Hiroki
    Iwanaga, Akito
    Seki, Keiichi
    Honma, Terasu
    Yoshida, Toshiaki
    [J]. HEPATOLOGY RESEARCH, 2014, 44 (11) : 1056 - 1061
  • [10] Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach-The ALBI Grade
    Johnson, Philip J.
    Berhane, Sarah
    Kagebayashi, Chiaki
    Satomura, Shinji
    Teng, Mabel
    Reeves, Helen L.
    O'Beirne, James
    Fox, Richard
    Skowronska, Anna
    Palmer, Daniel
    Yeo, Winnie
    Mo, Frankie
    Lai, Paul
    Inarrairaegui, Mercedes
    Chan, Stephen L.
    Sangro, Bruno
    Miksad, Rebecca
    Tada, Toshifumi
    Kumada, Takashi
    Toyoda, Hidenori
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (06) : 550 - U45